Literature DB >> 19219011

Building a new conceptual framework for receptor heteromers.

Sergi Ferré1, Ruben Baler, Michel Bouvier, Marc G Caron, Lakshmi A Devi, Thierry Durroux, Kjell Fuxe, Susan R George, Jonathan A Javitch, Martin J Lohse, Ken Mackie, Graeme Milligan, Kevin D G Pfleger, Jean-Philippe Pin, Nora D Volkow, Maria Waldhoer, Amina S Woods, Rafael Franco.   

Abstract

Receptor heteromers constitute a new area of research that is reshaping our thinking about biochemistry, cell biology, pharmacology and drug discovery. In this commentary, we recommend clear definitions that should facilitate both information exchange and research on this growing class of transmembrane signal transduction units and their complex properties. We also consider research questions underlying the proposed nomenclature, with recommendations for receptor heteromer identification in native tissues and their use as targets for drug development.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19219011      PMCID: PMC2681085          DOI: 10.1038/nchembio0309-131

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  29 in total

Review 1.  Neurotrophins and their receptors: a convergence point for many signalling pathways.

Authors:  Moses V Chao
Journal:  Nat Rev Neurosci       Date:  2003-04       Impact factor: 34.870

Review 2.  International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on terms and symbols in quantitative pharmacology.

Authors:  Richard R Neubig; Michael Spedding; Terry Kenakin; Arthur Christopoulos
Journal:  Pharmacol Rev       Date:  2003-12       Impact factor: 25.468

3.  Dimer-based model for heptaspanning membrane receptors.

Authors:  Rafael Franco; Vicent Casadó; Josefa Mallol; Sergi Ferré; Kjell Fuxe; Antonio Cortés; Francisco Ciruela; Carmen Lluis; Enric I Canela
Journal:  Trends Biochem Sci       Date:  2005-07       Impact factor: 13.807

4.  D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum.

Authors:  Asim J Rashid; Christopher H So; Michael M C Kong; Teresa Furtak; Mufida El-Ghundi; Regina Cheng; Brian F O'Dowd; Susan R George
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-28       Impact factor: 11.205

Review 5.  Functional relevance of neurotransmitter receptor heteromers in the central nervous system.

Authors:  Sergi Ferré; Francisco Ciruela; Amina S Woods; Carme Lluis; Rafael Franco
Journal:  Trends Neurosci       Date:  2007-08-10       Impact factor: 13.837

6.  Identification of dopamine D1-D3 receptor heteromers. Indications for a role of synergistic D1-D3 receptor interactions in the striatum.

Authors:  Daniel Marcellino; Sergi Ferré; Vicent Casadó; Antonio Cortés; Bernard Le Foll; Carmen Mazzola; Filippo Drago; Oliver Saur; Holger Stark; Aroa Soriano; Chanel Barnes; Steven R Goldberg; Carme Lluis; Kjell Fuxe; Rafael Franco
Journal:  J Biol Chem       Date:  2008-07-21       Impact factor: 5.157

7.  Opioid-induced tolerance and dependence in mice is modulated by the distance between pharmacophores in a bivalent ligand series.

Authors:  David J Daniels; Natalie R Lenard; Chris L Etienne; Ping-Yee Law; Sandra C Roerig; Philip S Portoghese
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

8.  A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein.

Authors:  Matthew R Whorton; Michael P Bokoch; Søren G F Rasmussen; Bo Huang; Richard N Zare; Brian Kobilka; Roger K Sunahara
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-23       Impact factor: 11.205

9.  Efficient coupling of transducin to monomeric rhodopsin in a phospholipid bilayer.

Authors:  Matthew R Whorton; Beata Jastrzebska; Paul S-H Park; Dimitrios Fotiadis; Andreas Engel; Krzysztof Palczewski; Roger K Sunahara
Journal:  J Biol Chem       Date:  2007-11-22       Impact factor: 5.157

Review 10.  International Union of Basic and Clinical Pharmacology. LXVII. Recommendations for the recognition and nomenclature of G protein-coupled receptor heteromultimers.

Authors:  Jean-Philippe Pin; Richard Neubig; Michel Bouvier; Lakshmi Devi; Marta Filizola; Jonathan A Javitch; Martin J Lohse; Graeme Milligan; Krzysztof Palczewski; Marc Parmentier; Michael Spedding
Journal:  Pharmacol Rev       Date:  2007-03       Impact factor: 25.468

View more
  168 in total

Review 1.  Ingestion-controlling network: what's language got to do with it?

Authors:  Michael Myslobodsky; Richard Coppola
Journal:  Rev Neurosci       Date:  2010       Impact factor: 4.353

Review 2.  On the expanding terminology in the GPCR field: the meaning of receptor mosaics and receptor heteromers.

Authors:  Luigi F Agnati; Diego Guidolin; Jean Pierre Vilardaga; Francisco Ciruela; Kjell Fuxe
Journal:  J Recept Signal Transduct Res       Date:  2010-10       Impact factor: 2.092

Review 3.  Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders.

Authors:  K Fuxe; D Marcellino; D O Borroto-Escuela; M Guescini; V Fernández-Dueñas; S Tanganelli; A Rivera; F Ciruela; L F Agnati
Journal:  CNS Neurosci Ther       Date:  2010-03-16       Impact factor: 5.243

4.  Trans-activation between 7TM domains: implication in heterodimeric GABAB receptor activation.

Authors:  Carine Monnier; Haijun Tu; Emmanuel Bourrier; Claire Vol; Laurent Lamarque; Eric Trinquet; Jean-Philippe Pin; Philippe Rondard
Journal:  EMBO J       Date:  2010-11-09       Impact factor: 11.598

Review 5.  Adenosine-cannabinoid receptor interactions. Implications for striatal function.

Authors:  Sergi Ferré; Carme Lluís; Zuzana Justinova; César Quiroz; Marco Orru; Gemma Navarro; Enric I Canela; Rafael Franco; Steven R Goldberg
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

6.  Interactions between intracellular domains as key determinants of the quaternary structure and function of receptor heteromers.

Authors:  Gemma Navarro; Sergi Ferré; Arnau Cordomi; Estefania Moreno; Josefa Mallol; Vicent Casadó; Antoni Cortés; Hanne Hoffmann; Jordi Ortiz; Enric I Canela; Carme Lluís; Leonardo Pardo; Rafael Franco; Amina S Woods
Journal:  J Biol Chem       Date:  2010-06-18       Impact factor: 5.157

Review 7.  Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes.

Authors:  Nicola J Smith; Graeme Milligan
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 8.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Authors:  R G Pertwee; A C Howlett; M E Abood; S P H Alexander; V Di Marzo; M R Elphick; P J Greasley; H S Hansen; G Kunos; K Mackie; R Mechoulam; R A Ross
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

9.  Cross-receptor interactions between dopamine D2L and neurotensin NTS1 receptors modulate binding affinities of dopaminergics.

Authors:  Susanne Koschatzky; Nuska Tschammer; Peter Gmeiner
Journal:  ACS Chem Neurosci       Date:  2011-04-11       Impact factor: 4.418

10.  Glucagon-like peptide-1 receptor dimerization differentially regulates agonist signaling but does not affect small molecule allostery.

Authors:  Kaleeckal G Harikumar; Denise Wootten; Delia I Pinon; Cassandra Koole; Alicja M Ball; Sebastian G B Furness; Bim Graham; Maoqing Dong; Arthur Christopoulos; Laurence J Miller; Patrick M Sexton
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.